Personalis at NeoAG Summit US: NOV 20-22, 2019
Presentation
Thursday, NOV 21 | 9:15 AM – 9:45 AM
Sean Michael Boyle, PhD
Sr. Director, Bioinformatics Applications
Personalis, Inc.
ImmunoID NeXT: A Comprehensive Platform for Improving Neoantigen Prediction, Tumor Escape Mechanism Reporting, TME Assessment, and Tumor Heterogeneity Profiling for Immuno-Oncology
- Improving neoantigen presentation prediction – Applying immunopeptidomics and machine learning to more accurately predict neoantigens
- Detecting tumor escape mechanisms – HLA LOH, antigen presentation machinery, and immunogenomics
- Profiling tumor heterogeneity – Utilizing cell free DNA in order to more comprehensively identify neoantigens and tumor escape mechanisms